Archive for August 2018
Immunexpress Saving Lives with Improved Sepsis Diagnosis: Interview with Rolland Carlson PhD, CEO
Medgadget editor Tom Peach sat down with Dr.Carlson from Immunexpress to hear more about the company’s first FDA-approved sepsis diagnostic test, SeptiCyte, and what the future of sepsis diagnosis and treatment may look like.
Read More3 Need-to-Know Leaps in Sepsis Care
Rolland Carlson, PhD, CEO of Immunexpress, discusses a different approach to the sepsis battle. Rather than passively chasing pathogens, the Company has developed a test to measure the body’s specific immune response to infection by examining biomarkers in the patient’s blood.
Read MoreImmunexpress is proud to be one of the sponsors for the 2nd World Sepsis Conference, Sept 5-6, 2018
“The 2nd World Sepsis Congress will be held on September 5th and 6th, 2018 – free of charge and completely online, so you can participate from wherever you have an internet connection. Over the course of 17 sessions, more than 100 speakers from 30 countries will discuss all aspects of sepsis and its wide-ranging consequences.…
Read MoreImmunexpress wins the 2018 MedTech Best Proof-of-Value of an Innovation award
“LONDON – AUGUST 13, 2018 – Informa Pharma Intelligence today announces the finalists for the 2018 Medtech Insight Awards. The diverse group of finalists were chosen by a highly respected independent panel of experts from across the sector.” — Pharma Intelligence https://pharmaintelligence.informa.com/events/awards/medtech-insight-awards-2018
Read More